Literature DB >> 944086

Idiopathic thrombocytopenic purpura in lymphoma.

K Fink, H Al-Mondhiry.   

Abstract

Five patients with idiopathic thrombocytopenic purpura (ITP) associated with malignant lymphoma are presented, and twelve other cases reported in the literature are reviewed. Thirteen patients (76%) had Hodgkin's disease; two had diffuse histiocytic, one, diffuse mixed lymphoma. Idiopathic thrombocytopenic purpura presented as the sole clinical manifestation of initial or recurrent lymphoma in 10 of 15 cases (67%). The spleen was not palpable even in patients who showed involvement with lymphoma at splenectomy. Three patients were asplenic at the onset of idiopathic thrombocytopenic purpura. Successful therapy of the thrombocytopenia correlated with effective control of the underlying lymphoma. Splenectomy gave favorable results in 9 of 10 cases (90%) and uncovered occult lymphoma in five patients. Chemotherapeutic drugs were successful in seven of 12 trials (58%) and only when the underlying disease was also controlled. The overall prognosis was related to the status of the lymphoma and was not altered by the occurrence of the idiopathic thrombocytopenic purpura.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944086     DOI: 10.1002/1097-0142(197604)37:4<1999::aid-cncr2820370451>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Hodgkin's disease presenting as idiopathic thrombocytopenic purpura.

Authors:  W G Murphy; N C Allan; D J Perry; G Stockdill
Journal:  Postgrad Med J       Date:  1984-09       Impact factor: 2.401

Review 2.  Hemostatic changes in patients with malignancy.

Authors:  G H Goldsmith
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

3.  Autoimmune neutropenia preceding Helicobacter pylori-negative MALT lymphoma with nodal dissemination.

Authors:  Saori Harada; Sho Yamazaki; Fumihiko Nakamura; Ken Morita; Akihide Yoshimi; Aya Shinozaki-Ushiku; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results.

Authors:  O E Akwari; K M Itani; R E Coleman; W F Rosse
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

Review 5.  Surgical treatment of immune thrombocytopenic purpura.

Authors:  P Chirletti; M Cardi; P Barillari; A Vitale; P Sammartino; A Bolognese; R Caiazzo; M Ricci; I A Muttillo; V Stipa
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

6.  Idiopathic thrombocytopenic purpura in women with breast cancer.

Authors:  Mozhgan Alam Samimi; Nooshin Mirkheshti; Mitra Heidarpour; Mozhgan Abdollahi
Journal:  J Res Med Sci       Date:  2010-11       Impact factor: 1.852

7.  Lymphomas diagnosed in an internal medicine department compared to lymphomas diagnosed in other departments: Clinical and outcome differences.

Authors:  Benoit Pernot; Emmanuel Gyan; François Maillot; Penelope Hodges; Marjan Ertault; Nicole Ferreira-Maldent
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

8.  Idiopathic thrombocytopenic purpura after mastectomy and axillary lymph node dissection.

Authors:  Wil L Santivasi; Meghan M Routt; Alicia M Terando
Journal:  Case Rep Surg       Date:  2014-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.